These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 38500284)

  • 1. The Application of Nanotechnological Therapeutic Platforms against Gynecological Cancers.
    Keyvani V; Mollazadeh S; Riahi E; Mahmoudian RA; Tabari M; Lagzian E; Ghorbani E; Akbarzade H; Gholami AS; Gataa IS; Hassanian SM; Ferns GA; Khazaei M; Avan A; Anvari K
    Curr Pharm Des; 2024; 30(13):975-987. PubMed ID: 38500284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Horizons of nanotechnology applications in female specific cancers.
    Rajitha B; Malla RR; Vadde R; Kasa P; Prasad GLV; Farran B; Kumari S; Pavitra E; Kamal MA; Raju GSR; Peela S; Nagaraju GP
    Semin Cancer Biol; 2021 Feb; 69():376-390. PubMed ID: 31301361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnological Advances in the Diagnosis of Gynecological Cancers and Nanotheranostics.
    Keyvani V; Mollazadeh S; Riahi E; Mahmoudian RA; Anvari K; Avan A
    Curr Pharm Des; 2024 Jul; ():. PubMed ID: 39021196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boosting antitumor efficacy using docetaxel-loaded nanoplatforms: from cancer therapy to regenerative medicine approaches.
    Beheshtizadeh N; Amiri Z; Tabatabaei SZ; Seraji AA; Gharibshahian M; Nadi A; Saeinasab M; Sefat F; Kolahi Azar H
    J Transl Med; 2024 May; 22(1):520. PubMed ID: 38816723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of lipid-engineered nanoplatforms in the delivery of various cancer therapeutics to surmount breast cancer.
    Gupta U; Saren BN; Khaparkhuntikar K; Madan J; Singh PK
    J Control Release; 2022 Aug; 348():1089-1115. PubMed ID: 35640765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives.
    Edis Z; Wang J; Waqas MK; Ijaz M; Ijaz M
    Int J Nanomedicine; 2021; 16():1313-1330. PubMed ID: 33628022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-angiogenic drugs currently in Phase II clinical trials for gynecological cancer treatment.
    Wei XW; Zhang ZR; Wei YQ
    Expert Opin Investig Drugs; 2013 Sep; 22(9):1181-92. PubMed ID: 23782133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced and Prolonged Antitumor Effect of Salinomycin-Loaded Gelatinase-Responsive Nanoparticles via Targeted Drug Delivery and Inhibition of Cervical Cancer Stem Cells.
    Wang Q; Liu F; Wang L; Xie C; Wu P; Du S; Zhou S; Sun Z; Liu Q; Yu L; Liu B; Li R
    Int J Nanomedicine; 2020; 15():1283-1295. PubMed ID: 32161458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug delivery approaches for breast cancer.
    Singh SK; Singh S; Lillard JW; Singh R
    Int J Nanomedicine; 2017; 12():6205-6218. PubMed ID: 28883730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.
    Ali ES; Sharker SM; Islam MT; Khan IN; Shaw S; Rahman MA; Uddin SJ; Shill MC; Rehman S; Das N; Ahmad S; Shilpi JA; Tripathi S; Mishra SK; Mubarak MS
    Semin Cancer Biol; 2021 Feb; 69():52-68. PubMed ID: 32014609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential cytotoxic and anti-metastatic effects of berberine on gynaecological cancers with drug-associated resistance.
    Mortazavi H; Nikfar B; Esmaeili SA; Rafieenia F; Saburi E; Chaichian S; Heidari Gorji MA; Momtazi-Borojeni AA
    Eur J Med Chem; 2020 Feb; 187():111951. PubMed ID: 31821990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanotechnological approaches for diagnosis and treatment of ovarian cancer: a review of recent trends.
    Ding H; Zhang J; Zhang F; Xu Y; Liang W; Yu Y
    Drug Deliv; 2022 Dec; 29(1):3218-3232. PubMed ID: 36259505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptidyl-prolyl cis/trans isomerase NIMA-interacting 1 as a molecular target in breast cancer: a therapeutic perspective of gynecological cancer.
    Kim G; Bhattarai PY; Choi HS
    Arch Pharm Res; 2019 Feb; 42(2):128-139. PubMed ID: 30684192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive approach of hybrid nanoplatforms in drug delivery and theranostics to combat cancer.
    Thorat ND; Townley HE; Patil RM; Tofail SAM; Bauer J
    Drug Discov Today; 2020 Jul; 25(7):1245-1252. PubMed ID: 32371139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Fluorouracil nano-delivery systems as a cutting-edge for cancer therapy.
    Valencia-Lazcano AA; Hassan D; Pourmadadi M; Shamsabadipour A; Behzadmehr R; Rahdar A; Medina DI; Díez-Pascual AM
    Eur J Med Chem; 2023 Jan; 246():114995. PubMed ID: 36493619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer Properties of Baicalin against Breast Cancer and other Gynecological Cancers: Therapeutic Opportunities based on Underlying Mechanisms.
    Pourhanifeh MH; Farrokhi-Kebria H; Mostanadi P; Farkhondeh T; Samarghandian S
    Curr Mol Pharmacol; 2024; 17():e18761429263063. PubMed ID: 38284731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of retinoblastoma: opportunities and challenges.
    Bhavsar D; Subramanian K; Sethuraman S; Krishnan UM
    Drug Deliv; 2016 Sep; 23(7):2488-2496. PubMed ID: 25758593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnology Assisted Chemotherapy for Targeted Cancer Treatment: Recent Advances and Clinical Perspectives.
    Lan HR; Wu ZQ; Zhang LH; Jin KT; Wang SB
    Curr Top Med Chem; 2020; 20(27):2442-2458. PubMed ID: 32703133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of Lipid-based Nanoparticles to Improve the Therapeutic Benefits of Bortezomib.
    Korani M; Korani S; Zendehdel E; Jaafari MR; Sathyapalan T; Sahebkar A
    Anticancer Agents Med Chem; 2020; 20(6):643-650. PubMed ID: 31985384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.